Lars Fruergaard Jørgensen

Lars Fruergaard Jørgensen

business executive Denmark

Lars Fruergaard Jørgensen is the CEO of Novo Nordisk, a leading global healthcare company based in Denmark that specializes in diabetes care and hormone replacement therapies. Under his leadership, the company has focused on innovation and sustainability, driving advancements in diabetes medications and weight management solutions. Recently, he has been vocal about the challenges of high drug prices in the U.S., addressing issues related to pharmacy benefit managers and the pricing mechanisms that affect patient access to medications.

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
59,884
Power
2,894$
Sentiment
4.73
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Denmark 4 5.25 0.27% +0% 5,792,202 15,498 $350,000 936$
Norway 2 4.50 0.16% +0% 5,421,241 8,524 $403,000 634$
United Kingdom 1 5.00 0.04% +0% 67,886,011 23,920 $2,700,000 951$
Sweden 1 4.00 0.06% +0% 10,099,265 5,821 $530,000 305$
Slovakia 1 3.00 0.06% +0% 5,459,642 3,172 $110,000 64$
Ireland 1 4.00 0.06% +0% 5,030,000 2,948 $5,100 3$
Totals 10 99,688,361 59,883 $4,098,100 2,893$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Denmark Denmark: The outgoing CEO of Novo Nordisk, Lars Fruergaard Jørgensen, received a letter from President Trump regarding product pricing. 5

Politiken: Novos kursfald mindskes efter historie om amerikansk Medicare-dækning af vægttabsmedicin

Denmark Denmark: Lars Fruergaard Jørgensen is the outgoing CEO of Novo Nordisk. 6

Politiken: Trump sender brev til Novo Nordisk

Slovakia Slovakia: Lars Fruergaard Jørgensen was removed as CEO of Novo Nordisk for failing to maintain the company's leading position. 3

SME – major Slovak daily, est. 1993: Najhodnotnejšia firma Európy ťahala HDP celej krajiny. Prečo zrazu prudko padá?

Sweden Sweden: Lars Fruergaard Jørgensen was removed from his position as CEO of Novo Nordisk earlier in the summer. 4

Dagens Nyheter: Novo Nordisk rasar på börsen efter sänkta prognoser

Denmark Denmark: Lars Fruergaard Jørgensen is stepping down as CEO of Novo Nordisk. 5

Politiken: Novo Nordisk offentliggør stor nedjustering for 2025

Denmark Denmark: Lars Fruergaard Jørgensen will step down after eight years as the CEO of Novo Nordisk. 5

Politiken: Novo Nordisk udpeger ny topchef midt i aktiestyrtdyk

Norway Norway: Lars Fruergaard Jørgensen was the CEO of Novo Nordisk who saw significant growth in the company before being dismissed. 4

Aftenposten: Danmark har skapt et slankeeventyr. Nå er de i trøbbel.

Norway Norway: Lars Fruergaard Jørgensen was the CEO of Novo Nordisk who saw the company's sales and stock price triple since he took over in 2017. 5

Aftenposten: Danmark har skapt et slankeeventyr. Nå er de i trøbbel.